IRIS Accounts Production v25.2.0.378 05528792 director 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh055287922023-12-31055287922024-12-31055287922024-01-012024-12-31055287922022-12-31055287922023-01-012023-12-31055287922023-12-3105528792ns15:EnglandWales2024-01-012024-12-3105528792ns14:PoundSterling2024-01-012024-12-3105528792ns10:Director12024-01-012024-12-3105528792ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3105528792ns10:SmallEntities2024-01-012024-12-3105528792ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3105528792ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3105528792ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3105528792ns10:FullAccounts2024-01-012024-12-3105528792ns10:OrdinaryShareClass12024-01-012024-12-3105528792ns10:CompanySecretary12024-01-012024-12-3105528792ns10:RegisteredOffice2024-01-012024-12-3105528792ns5:CurrentFinancialInstruments2024-12-3105528792ns5:CurrentFinancialInstruments2023-12-3105528792ns5:ShareCapital2024-12-3105528792ns5:ShareCapital2023-12-3105528792ns5:RetainedEarningsAccumulatedLosses2024-12-3105528792ns5:RetainedEarningsAccumulatedLosses2023-12-3105528792ns5:ComputerEquipment2023-12-3105528792ns5:ComputerEquipment2024-01-012024-12-3105528792ns5:ComputerEquipment2024-12-3105528792ns5:ComputerEquipment2023-12-3105528792ns10:OrdinaryShareClass12024-12-3105528792ns5:RetainedEarningsAccumulatedLosses2023-12-3105528792ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-31
REGISTERED NUMBER: 05528792 (England and Wales)















Unaudited Financial Statements

for the Year Ended 31 December 2024

for

CYGNETS NURSERY LIMITED

CYGNETS NURSERY LIMITED (REGISTERED NUMBER: 05528792)

Contents of the Financial Statements
for the year ended 31 December 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


CYGNETS NURSERY LIMITED

Company Information
for the year ended 31 December 2024







Director: Mrs R Gelver





Secretary: J Gelver





Registered office: 3rd Floor
86-90 Paul Street
London
EC2A 4NE





Registered number: 05528792 (England and Wales)





Accountants: Farnborough

CYGNETS NURSERY LIMITED (REGISTERED NUMBER: 05528792)

Balance Sheet
31 December 2024

2024 2023
Notes £ £ £ £
Fixed assets
Tangible assets 4 5,511 7,348

Current assets
Cash at bank and in hand 47,434 49,115

Creditors
Amounts falling due within one year 5 10,245 6,851
Net current assets 37,189 42,264
Total assets less current liabilities 42,700 49,612

Capital and reserves
Called up share capital 6 100 100
Retained earnings 7 42,600 49,512
Shareholders' funds 42,700 49,612

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 September 2025 and were signed by:





Mrs R Gelver - Director


CYGNETS NURSERY LIMITED (REGISTERED NUMBER: 05528792)

Notes to the Financial Statements
for the year ended 31 December 2024


1. Statutory information

Cygnets Nursery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Key source of estimation, uncertainty and judgement
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Turnover
Turnover represents the consideration receivable for services rendered.

Tangible fixed assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairments losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Equipment 25% per annum on reducing balances

Financial instruments
Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

Taxation
Taxation for the year comprises current tax.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

CYGNETS NURSERY LIMITED (REGISTERED NUMBER: 05528792)

Notes to the Financial Statements - continued
for the year ended 31 December 2024


3. Employees and directors

The average number of employees during the year was 5 (2023 - 5 ) .

4. Tangible fixed assets
Equipment
£
Cost
At 1 January 2024
and 31 December 2024 37,094
Depreciation
At 1 January 2024 29,746
Charge for year 1,837
At 31 December 2024 31,583
Net book value
At 31 December 2024 5,511
At 31 December 2023 7,348

5. Creditors: amounts falling due within one year
2024 2023
£ £
Corporation tax 3,496 2,676
Social security and other taxes - 736
Other creditors 746 634
Directors' current accounts 3,903 706
Accruals and deferred income 2,100 2,099
10,245 6,851

6. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £ £
100 Ordinary 1 100 100

7. Reserves
Retained
earnings
£

At 1 January 2024 49,512
Profit for the year 13,088
Dividends (20,000 )
At 31 December 2024 42,600